Skip to main content

Cefoperazone Pregnancy and Breastfeeding Warnings

Brand names: Cefobid

Cefoperazone Pregnancy Warnings

Cefoperazone has been assigned to pregnancy category B by the FDA. Animal studies failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy. Cefoperazone should only be given during pregnancy when need has been clearly established.

See references

Cefoperazone Breastfeeding Warnings

Cefoperazone is excreted into human milk in small amounts. Adverse effects in the nursing infant are unlikely. Other cephalosporins have been classified as compatible with breast-feeding by the American Academy of Pediatrics.

See references

References for pregnancy information

  1. Product Information. Cefobid (cefoperazone). Roerig Division. 2002;PROD.
  2. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. Use of cephalosporins during pregnancy and in the presence of congenital abnormalities: A population-based, case-control study. Am J Obstet Gynecol. 2001;184:1289-96.

References for breastfeeding information

  1. Product Information. Cefobid (cefoperazone). Roerig Division. 2002;PROD.
  2. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. Baltimore, MD: Williams & Wilkins. 1998.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.